Depomed Inc. About
Depomed Inc Depomed, Inc. is a specialty pharmaceutical
company with a strong focus on drug
delivery. dEPOMED IS developing new and proprietary
oral delivery technologies to improve
pharmaceutical products. Their strategy
is to develop proprietary products and
to establish collaborations with pharmaceutical,
biotechnology, and generic companies to
develop and commercialize products utilizing
the Depomed systems. Depomed's Gastric Retention (GR™) systems
are unique in that they are simple, effective
and revolutionary. Using swelling polymers
that are commonly used in the food and
drug industry, their technologies control
drug delivery over time and lengthen the
time a tablet remains in the upper gastrointestinal
tract, which often results in increased
bioavailability, less frequent dosing
and possibly fewer side effects. Product
Pipeline Data for Depomed Glumetza for Tyope II diabetes; Proquin XR( Urinary Tract Infections),
Furosemide (congestive heart failure),
GR, Gabapentin (siezures). More
on Depomed